Sysmex (OTCMKTS:SSMXY) Sees Large Volume Increase – Here’s What Happened

Sysmex Corporation ADR (OTCMKTS:SSMXY) saw strong trading volume on Thursday . 734,187 shares were traded during trading, an increase of 471% from the previous session’s volume of 128,685 shares.The stock last traded at $9.28 and had previously closed at $9.59.

Wall Street Analysts Forecast Growth

SSMXY has been the topic of several analyst reports. The Goldman Sachs Group raised Sysmex from a “hold” rating to a “buy” rating in a research note on Thursday, October 9th. Zacks Research upgraded Sysmex from a “strong sell” rating to a “hold” rating in a report on Thursday, August 14th. One analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat, Sysmex has an average rating of “Moderate Buy”.

Sysmex Price Performance

The company has a debt-to-equity ratio of 0.12, a quick ratio of 2.49 and a current ratio of 3.37. The company has a market capitalization of $5.79 billion, a P/E ratio of 18.40 and a beta of 1.16. The firm’s fifty day moving average is $11.71 and its 200 day moving average is $14.47.

Sysmex (OTCMKTS:SSMXY) last released its earnings results on Wednesday, November 5th. The company reported $0.16 EPS for the quarter, meeting analysts’ consensus estimates of $0.16. Sysmex had a return on equity of 10.20% and a net margin of 9.35%.The firm had revenue of $826.60 million for the quarter, compared to analysts’ expectations of $880.80 million. As a group, analysts predict that Sysmex Corporation ADR will post 0.57 earnings per share for the current fiscal year.

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.